Evidence map›Paper›PMID 34627560›Full record

ArticleThe Lancet. Respiratory medicine2021

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

Rachael A Evans, Hamish McAuley, Ewen M Harrison, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Omer Elneima, Annemarie B Docherty, Nazir I Lone, Olivia C Leavy and 44 more

Erratum issued 2 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in The Lancet. Respiratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 398 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
398citing papers in PubMed, 9 pooled it
59.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05736939 completednot on this mapstarted 2022, after this paper: background citation

Gender Differences in the Recovery Rate Following a Hybrid Pulmonary Rehabilitation Programme in Patients With Long COVID-19 Syndrome

TypeobservationalSponsorNational and Kapodistrian University of AthensRan2022 to 2023Enrolled30ConditionsPost Acute COVID-19 SyndromeArmsOut-patient Pulmonary Rehabilitation
NCT05890508 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms: a Prospective, Randomized Sham-controlled, Double-blinded Clinical Trial

TypeinterventionalSponsorHong Kong Baptist UniversityRan2024 to 2026Enrolled150ConditionsLong Covid19, Neuropsychiatric Symptoms, Electro-acupunctureArmsAcupuncture, Sham-acupuncture
3 · Its place in the literature

Who cites it

398 citing papers in PubMed, 9 syntheses or guidelines pooled it, 642 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review.International journal of environmental research and public health · 2024
    Pooled it
  8. Pooled it
  9. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. LongitudinalJournal of magnetic resonance imaging : JMRI · 2026
    Article

338 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 2 countries.

Rachael A EvansInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Hamish McAuleyInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Ewen M HarrisonUsher Institute, University of Edinburgh, Edinburgh, UK.
Aarti ShikotraInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Amisha SingapuriInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Marco SerenoInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Omer ElneimaInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Annemarie B DochertyUsher Institute, University of Edinburgh, Edinburgh, UK.
Nazir I LoneUsher Institute, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Olivia C LeavyDepartment of Health Sciences, University of Leicester, Leicester, UK.
Luke DainesUsher Institute, University of Edinburgh, Edinburgh, UK.
J Kenneth BaillieRoslin Institute, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Jeremy S BrownUCL Respiratory, Department of Medicine, University College London, London, UK.
Trudie ChalderDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Anthony De SoyzaPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK; Newcastle upon Tyne Teaching Hospitals Trust, Newcastle upon Tyne, UK.
Nawar Diar BakerlyManchester Metropolitan University, Manchester, UK; Salford Royal NHS Foundation Trust, Manchester, UK.
Nicholas EasomInfection Research Group, Hull University Teaching Hospitals, Hull, UK.
John R GeddesNIHR Oxford Health Biomedical Research Centre, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK.
Neil J GreeningInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Nick HartLane Fox Respiratory Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Liam G HeaneyWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK; Belfast Health & Social Care Trust, Belfast, UK.
Simon HellerDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Luke HowardImperial College Healthcare NHS Trust, London, UK, University College London, London, UK.
John R HurstUCL Respiratory, Department of Medicine, University College London, London, UK.
Joseph JacobCentre for Medical Image Computing, University College London, London, UK; Lungs for Living Research Centre, University College London, London, UK.
R Gisli JenkinsNational Heart and Lung Institute, Imperial College London, London, UK.
Caroline JolleyCentre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Steven KerrRoslin Institute, University of Edinburgh, Edinburgh, UK.
Onn M KonImperial College Healthcare NHS Trust, London, UK, University College London, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
Keir LewisHywel Dda University Health Board, Wales, UK; University of Swansea, Swansea, UK; Respiratory Innovation Wales, Llanelli, UK.
Janet M LordInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Gerry P McCannDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK; Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Stefan NeubauerNIHR Oxford Health Biomedical Research Centre, University of Oxford, Oxford, UK; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Peter J M OpenshawNational Heart and Lung Institute, Imperial College London, London, UK.
Dhruv ParekhInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; Department of Acute Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Paul PfefferBarts Health NHS Trust, London, UK; Queen Mary University of London, London, UK.
Najib M RahmanOxford Respiratory Trials Unit, University of Oxford, Oxford, UK.
Betty RamanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Matthew RichardsonInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Matthew RowlandKadoorie Centre for Critical Care Research, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Malcolm G SempleNIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK; Respiratory Medicine, Alder Hey Children's Hospital, Liverpool, UK.
Ajay M ShahKing's College London British Heart Foundation Centre and King's College Hospital NHS Foundation Trust, London, UK.
Sally J SinghInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Aziz SheikhUsher Institute, University of Edinburgh, Edinburgh, UK.
David ThomasImmunology and Inflammation, Imperial College London, London, UK.
Mark ToshnerCambridge NIHR Biomedical Research Centre, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK.
James D ChalmersUniversity of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Ling-Pei HoMRC Human Immunology Unit, University of Oxford, Oxford, UK.
Alex HorsleyDivision of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Michael MarksDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospital, London, UK.
Krisnah PoinasamyAsthma UK and British Lung Foundation, London, UK.
Louise V WainInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK; Department of Health Sciences, University of Leicester, Leicester, UK.
Christopher E BrightlingInstitute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK. Electronic address: ceb17@le.ac.uk.
PHOSP-COVID Collaborative Group
University of Leicester · GBGuy's and St Thomas' NHS Foundation Trust · GBOxford Health NHS Foundation Trust · GBUniversity of Hull · GBManchester Metropolitan University · GBUniversity College London · GBUniversity of Edinburgh · GBKing's College London · GBNewcastle upon Tyne Hospital · GBNHS Lothian · GBImperial College Healthcare NHS Trust · GBNIHR Leicester Biomedical Research Centre · GBUniversity of Oxford · GBImperial College London · GBQueen's University Belfast · GBRoslin Institute · GBSwansea Bay University Health Board · GBUniversity of Birmingham · GBUniversity of Dundee · GBUniversity of Liverpool · GB

Funding

British Heart Foundation CH/16/1/32013British Heart Foundation CH/1999001/11735British Heart Foundation FS/18/13/33281British Heart Foundation SP/14/6/31350British Heart Foundation SP/17/16/33519Medical Research Council G0501425Medical Research Council G0600520Medical Research Council G0700859Medical Research Council G0801952Medical Research Council G1000191Medical Research Council G1001046Medical Research Council MC_PC_19025Medical Research Council MC_PC_19026Medical Research Council MC_PC_19059Medical Research Council MC_PC_20016Medical Research Council MC_UU_00008/11Medical Research Council MC_UU_12014/8Medical Research Council MR/L018942/1Medical Research Council MR/M008894/1Medical Research Council MR/P021220/1Medical Research Council MR/S019669/1Medical Research Council MR/T005580/1Medical Research Council MR/V027859/1Wellcome Trust 206330/Z/17/ZWellcome Trust 209553/Z/17/Z
6 · The paper itself

Abstract

backgroundThe impact of COVID-19 on physical and mental health and employment after hospitalisation with acute disease is not well understood. The aim of this study was to determine the effects of COVID-19-related hospitalisation on health and employment, to identify factors associated with recovery, and to describe recovery phenotypes.

methodsThe Post-hospitalisation COVID-19 study (PHOSP-COVID) is a multicentre, long-term follow-up study of adults (aged ≥18 years) discharged from hospital in the UK with a clinical diagnosis of COVID-19, involving an assessment between 2 and 7 months after discharge, including detailed recording of symptoms, and physiological and biochemical testing. Multivariable logistic regression was done for the primary outcome of patient-perceived recovery, with age, sex, ethnicity, body-mass index, comorbidities, and severity of acute illness as covariates. A post-hoc cluster analysis of outcomes for breathlessness, fatigue, mental health, cognitive impairment, and physical performance was done using the clustering large applications k-medoids approach. The study is registered on the ISRCTN Registry (ISRCTN10980107).

findingsWe report findings for 1077 patients discharged from hospital between March 5 and Nov 30, 2020, who underwent assessment at a median of 5·9 months (IQR 4·9-6·5) after discharge. Participants had a mean age of 58 years (SD 13); 384 (36%) were female, 710 (69%) were of white ethnicity, 288 (27%) had received mechanical ventilation, and 540 (50%) had at least two comorbidities. At follow-up, only 239 (29%) of 830 participants felt fully recovered, 158 (20%) of 806 had a new disability (assessed by the Washington Group Short Set on Functioning), and 124 (19%) of 641 experienced a health-related change in occupation. Factors associated with not recovering were female sex, middle age (40-59 years), two or more comorbidities, and more severe acute illness. The magnitude of the persistent health burden was substantial but only weakly associated with the severity of acute illness. Four clusters were identified with different severities of mental and physical health impairment (n=767): very severe (131 patients, 17%), severe (159, 21%), moderate along with cognitive impairment (127, 17%), and mild (350, 46%). Of the outcomes used in the cluster analysis, all were closely related except for cognitive impairment. Three (3%) of 113 patients in the very severe cluster, nine (7%) of 129 in the severe cluster, 36 (36%) of 99 in the moderate cluster, and 114 (43%) of 267 in the mild cluster reported feeling fully recovered. Persistently elevated serum C-reactive protein was positively associated with cluster severity.

interpretationWe identified factors related to not recovering after hospital admission with COVID-19 at 6 months after discharge (eg, female sex, middle age, two or more comorbidities, and more acute severe illness), and four different recovery phenotypes. The severity of physical and mental health impairments were closely related, whereas cognitive health impairments were independent. In clinical care, a proactive approach is needed across the acute severity spectrum, with interdisciplinary working, wide access to COVID-19 holistic clinical services, and the potential to stratify care.

fundingUK Research and Innovation and National Institute for Health Research.

Indexed as

COVID-19Health StatusMental HealthAcute DiseaseAdultAgedCognitionComorbidityFemaleFollow-Up StudiesHospitalizationHumansMaleMiddle AgedProspective StudiesUnited Kingdom

Identifiers

PMID34627560
PMCPMC8497028
OpenAlexW3204570230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.